“The Venetoclax Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient With COVID : VEN AZA Effectively Targets AML Clones”. Mediterranean Journal of Hematology and Infectious Diseases 14, no. 1 (April 28, 2022): e2022041. Accessed April 18, 2026. https://www.mjhid.org/mjhid/article/view/4965.